Literature DB >> 8171052

Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement.

E W Thompson1.   

Abstract

The effects of severe, chronic diabetes mellitus and of immediate or delayed insulin replacement on the different components of the myocardium and cardiocytes were quantified and correlated. A significant decrease in cardiocyte cross-sectional area occurred during the first 12 weeks of diabetes and then stabilized. This was accompanied by decreases in the relative volume densities (RVDs) of myofibrils and mitochondria, resulting in absolute loss of more than 40% of each of these cellular components after 26 weeks of diabetes. Interstitial and perivascular deposition of extracellular matrix produced a tripling of its RVD in the myocardium over 26 weeks of diabetes at the expense of both cardiocytes and capillaries. Capillary density and diameter also exhibited progressive decreases of more than 20% over 26 weeks of diabetes. Insulin treatment which maintained euglycemia and restored normal growth prevented this structural pathology when begun three days after induction of diabetes. When delayed for 12 weeks, insulin reversed the changes in cardiocyte and capillary RVD, and in capillary diameter within 6 weeks, ultrastructural changes within 12 weeks, and cardiocyte cross-sectional area after 26 weeks. However, even after 26 weeks of treatment, the extracellular matrix remained more than twice that observed in nondiabetic animals, with a consequent decrease in the number of capillaries per unit volume of tissue. This study demonstrates that diabetes produces a progressive, marked disorganization of the myocardium which can be prevented, but only selectively reversed, by insulin treatment. These structural changes are relevant to the functional changes which occur in diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8171052     DOI: 10.3181/00379727-205-43710

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  14 in total

1.  Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.

Authors:  J D Sadoff; P M Scholz; J Tse; H R Weiss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.

Authors:  G de Simone; R B Devereux; M J Roman; M Chinali; A Barac; J A Panza; E T Lee; J M Galloway; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-09-21       Impact factor: 4.222

Review 3.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

4.  STIM1 restores coronary endothelial function in type 1 diabetic mice.

Authors:  Irene A Estrada; Reshma Donthamsetty; Patryk Debski; Meng-Hua Zhou; Shenyuan L Zhang; Jason X-J Yuan; Wenlong Han; Ayako Makino
Journal:  Circ Res       Date:  2012-08-14       Impact factor: 17.367

Review 5.  Treatment of heart failure in patients with diabetes mellitus.

Authors:  Steven J Lavine; Steven D Gellman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Determinants of subclinical diabetic heart disease.

Authors:  Z Y Fang; R Schull-Meade; M Downey; J Prins; T H Marwick
Journal:  Diabetologia       Date:  2005-01-08       Impact factor: 10.122

7.  Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart.

Authors:  T Hayashi; K Sohmiya; A Ukimura; S Endoh; T Mori; H Shimomura; M Okabe; F Terasaki; Y Kitaura
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

8.  The kinematic filling efficiency index of the left ventricle: contrasting normal vs. diabetic physiology.

Authors:  Wei Zhang; Charles S Chung; Matt M Riordan; Yue Wu; Leonid Shmuylovich; Sándor J Kovács
Journal:  Ultrasound Med Biol       Date:  2007-05-03       Impact factor: 2.998

9.  Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.

Authors:  Mahesh Thirunavukkarasu; Suresh Varma Penumathsa; Srikanth Koneru; Bela Juhasz; Lijun Zhan; Hajime Otani; Debasis Bagchi; Dipak K Das; Nilanjana Maulik
Journal:  Free Radic Biol Med       Date:  2007-05-10       Impact factor: 7.376

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.